• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Exagen Inc. - Common Stock (NQ:XGN)

6.450 +1.770 (+37.82%)
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 4, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Exagen Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >
News headline image
Nike, Tencent Music Entertainment And 3 Stocks To Watch Heading Into Tuesday ↗
March 21, 2023
With US futures trading higher this morning on Tuesday, some of the stocks that may grab investor focus today are as follows: 
Via Benzinga
News headline image
Exagen Inc. Reports Fourth Quarter and Full Year 2022 Results
March 20, 2023
Record AVISE® CTD Volume in 2022 
From Exagen Inc.
Via GlobeNewswire
News headline image
Exagen Earnings Preview ↗
March 17, 2023
 
Via Benzinga
News headline image
Exagen to Announce Fourth Quarter and Full Year Financial Results on March 20, 2023
March 06, 2023
From Exagen Inc.
Via GlobeNewswire
News headline image
Exagen Inc. to Participate in Upcoming March Conferences
February 27, 2023
From Exagen Inc.
Via GlobeNewswire
News headline image
Coya Therapeutics' Expansion Of Exclusive Worldwide Licensing Agreement With ARscience Biotherapeutics Could Have Outsized Impact On Neurodegenerative And Autoimmune Diseases Treatments ↗
February 15, 2023
Houston, Texas-based Coya Therapeutics Inc. (NASDAQ: COYA) has just taken a giant leap in making effective proprietary treatments focused on certain neurodegenerative and autoimmune diseases available... 
Via Benzinga
News headline image
Exagen Inc. to Participate in the 2023 BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
January 30, 2023
From Exagen Inc.
Via GlobeNewswire
News headline image
Exagen Inc. Elects Tina S. Nova, Ph.D. as Executive Chair of the Board of Directors
January 23, 2023
From Exagen Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
November 28, 2022
 
Via Benzinga
News headline image
Why Richardson Electronics Shares Surged Over 8%; Here Are 55 Biggest Movers From Friday ↗
November 28, 2022
Gainers AEye, Inc. (NASDAQ: LIDR) shares jumped 50% to close at $1.25 on Friday. AEye recently posted a Q3 loss of $0.11 per share. 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
November 25, 2022
 
Via Benzinga
News headline image
Why Lufax Holding Shares Are Trading Lower By Over 11%; Here Are 21 Stocks Moving Premarket ↗
November 25, 2022
Gainers VEON Ltd. (NASDAQ: VEON) shares rose 31.1% to $0.6095 in pre-market trading after the company agreed to sell its Russian business, Vimpelcom for 130 billion roubles ($2.2 billion). 
Via Benzinga
News headline image
Why Coupa Software Shares Jumped Around 29%; Here Are 72 Biggest Movers From Wednesday ↗
November 25, 2022
Gainers Kalera Public Limited Company (NASDAQ: KAL) jumped 76.9% to close at $0.1610 on Wednesday after gaining 9% on Tuesday. Kalera recently posted a Q3 loss of $0.05 per share. 
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
November 24, 2022
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
November 24, 2022
 
Via Benzinga
News headline image
Peering Into Exagen's Recent Short Interest ↗
November 17, 2022
Exagen's (NASDAQ:XGN) short percent of float has fallen 34.48% since its last report. The company recently reported that it has 20 thousand shares sold short, which is 0.19% of all regular shares that... 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
November 16, 2022
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
November 15, 2022
 
Via Benzinga
News headline image
Why Foresight Autonomous Shares Jumped 33%; Here Are 83 Biggest Movers From Yesterday ↗
November 17, 2022
Gainers Fast Radius, Inc. (NASDAQ: FSRD) shares surged 106.3% to close at $0.21 on Wednesday after dipping around 48% on Tuesday. Fast Radius established a timeline for a Chapter 11 sale process. 
Via Benzinga
News headline image
Why Target Shares Are Trading Lower By 14%? Here Are 56 Stocks Moving In Wednesday's Mid-Day Session ↗
November 16, 2022
Gainers Fast Radius, Inc. (NASDAQ: FSRD) shares jumped 109% to $0.2115 after dipping around 48% on Tuesday. Fast Radius established a timeline for a Chapter 11 sale process. 
Via Benzinga
News headline image
Pinterest To $23? Plus This Analyst Slashes PT On Neoleukin Therapeutics By More Than 90% ↗
November 15, 2022
Rosenblatt raised the price target on Pinterest, Inc. (NYSE: PINS) from $21 to $23. Rosenblatt analyst Barton Crockett maintained a Neutral rating on the stock. Pinterest shares rose 2% to $24.91 in... 
Via Benzinga
News headline image
Why Fast Radius Shares Plunged Around 48%; Here Are 103 Biggest Movers From Yesterday ↗
November 16, 2022
Gainers Satixfy Communications Ltd. (NYSE: SATX) shares gained 140.7% to settle at $31.80 on Tuesday. 
Via Benzinga
News headline image
Why Opiant Pharmaceuticals Shares Are Trading Higher By 115%? Here Are 67 Stocks Moving In Tuesday's Mid-Day Session ↗
November 15, 2022
Gainers SenesTech, Inc. (NASDAQ: SNES) shares surged 91.7% to $0.2751. SenesTech reported a 1-for-20 reverse stock split. 
Via Benzinga
News headline image
Exagen Inc. Reports Third Quarter 2022 Results
November 14, 2022
Medicare Reimbursement Returns 
From Exagen Inc.
Via GlobeNewswire
News headline image
Earnings Scheduled For November 14, 2022 ↗
November 14, 2022
Companies Reporting Before The Bell • Opiant Pharma (NASDAQ:OPNT) is estimated to report quarterly loss at $1.49 per share on revenue of $3.68 million. 
Via Benzinga
News headline image
Exagen Inc. to Participate in Fourth Quarter Investor Conferences
November 08, 2022
From Exagen Inc.
Via GlobeNewswire
News headline image
Exagen to Announce Third Quarter 2022 Financial Results on November 14, 2022
October 31, 2022
From Exagen Inc.
Via GlobeNewswire
News headline image
Stocks That Hit 52-Week Lows On Monday ↗
October 17, 2022
  During Monday's session, 101 companies made new 52-week lows. 
Via Benzinga
News headline image
Exagen Announces Appointment of John Aballi as CEO
October 17, 2022
From Exagen Inc.
Via GlobeNewswire
News headline image
Exagen Announces Appointment of Andrew L. Concoff MD, FACR, CAQSM, as Chief Innovation Officer
October 04, 2022
From Exagen Inc.
Via GlobeNewswire
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap